cGMP/Protein Kinase G-Dependent Potentiation of Glutamatergic Transmission Induced by Nitric Oxide in Immature Rat Rostral Ventrolateral Medulla Neurons in Vitro
Open Access
- 1 August 2003
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 64 (2) , 521-532
- https://doi.org/10.1124/mol.64.2.521
Abstract
Although both nitric oxide (NO) and glutamate within the rostral ventrolateral medulla (RVLM) are important mediators of the central cardiovascular regulation, little is known about the functional interactions between these two mediators. Herein, we investigated the possible role of NO on the glutamatergic transmission of RVLM neurons. Whole-cell patch-clamp recordings were performed on visualized RVLM neurons in the brainstem slice preparation of rats. We found that bath application of l-arginine, the substrate for NO production, significantly increased the amplitude of excitatory postsynaptic currents (EPSCs). This enhancement was completely abolished by coadministration of the NO synthase inhibitor 7-nitroindazole and mimicked by the NO donors 3-morpholinylsydnoneimine and spermine NONOate. Bath application of a NO-sensitive guanylyl cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, or a protein kinase G (PKG) inhibitor, Rp-8-bromo-guanosine 3′,5′-cyclic monophosphorothioate, fully prevented the l-arginine-, 3-morpholinylsydnoneimine-, and N-[4-[1-(3-aminopropyl)-2-hydroxy-2-nitrosohydrazino]-butyl]-1,3-propanediamin (spermine NONOate)-induced synaptic potentiation. Direct activation of PKG with 8-(4-chlorophenylthio)-cGMP mimicked the action of NO donors. Furthermore, the augmentation by spermine NONOate of EPSC was accompanied by a reduction of the paired-pulse facilitation and synaptic failure rate of EPSCs. Spermine NONOate also significantly increased the frequency of both spontaneous and miniature EPSCs without altering their amplitude distribution. Pretreatment with the N-type Ca2+ channel blocker ω-conotoxin GVIA selectively blocked the spermine NONOate-induced synaptic potentiation. These results suggest that NO acts presynaptically to elicit a synaptic potentiation on the RVLM neurons through an enhancement of presynaptic N-type Ca2+ channel activity leading to facilitating glutamate release. The presynaptic action of NO is mediated by a cGMP/PKG-coupled signaling pathway.Keywords
This publication has 42 references indexed in Scilit:
- Differential cardiovascular responses to blockade of nNOS or iNOS in rostral ventrolateral medulla of the ratBritish Journal of Pharmacology, 2001
- Pressor and sympathoexcitatory effects of nitric oxide in the rostral ventrolateral medullaJournal Of Hypertension, 1996
- Extracellular Activation of Unitary Excitatory Synapses Between Hippocampal CA3 and CA1 Pyramidal CellsEuropean Journal of Neuroscience, 1995
- Medullary visceral reflex circuits: Local afferents to nucleus tractus solitarii synthesize catecholamines and project to thoracic spinal cordJournal of Comparative Neurology, 1995
- The Nitric Oxide ‐ Cyclic GMP Pathway and Synaptic Depression in Rat Hippocampal SlicesEuropean Journal of Neuroscience, 1994
- The subretrofacial vasomotor nucleus: Anatomical, chemical and pharmacological properties and role in cardiovascular regulationProgress in Neurobiology, 1994
- Glutamate, nitric oxide and cell-cell signalling in the nervous systemTrends in Neurosciences, 1991
- Short-Term Synaptic PlasticityAnnual Review of Neuroscience, 1989
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- cGMP-dependent protein kinase enhances Ca2+ current and potentiates the serotonin-induced Ca2+ current increase in snail neuronesNature, 1986